Regen Report https://validator.w3.org/feed/docs/rss2.html Homepage FDA Clears AbelZeta’s CAR-T Trial for Progressive MS Webinar: Reimagining Gene-Modified T Cell Manufacturing – New Data on Integrating Isolation, Activation, Transduction, and Expansion in a Single Quantum Flex™ Workflow Mesenchymal Stem Cell Extracellular Vesicles Reprogram Microglia and Prevent Neurodegeneration in Alzheimer’s Models Fate Therapeutics Launches CAR T Trial for Lupus Nephritis Consano Bio’s Platelet-Derived Biologic May Ease Chronic Sciatica, New Study, Advancing RCT FDA Clears Colorado University Anschutz’ CAR T-Cell Trial for Colorectal Cancer Longeveron and Miller School Stem Cell Research Advances to Finals of XPRIZE Healthspan for Aging Frailty Humacyte’s Vascular Tissue Graft Nabs FDA Authorization for 36-Month Shelf Life iPSC-Derived Heart Cells Show Early Promise in Chinese Heart Failure Trial Kangstem Biotech’s Stem Cell for Knee Osteoarthritis Phase 2a Reports Significant Results Kolon’s Cell-Based Gene Therapy Fails Phase 3 Osteoarthritis Trial Sonoma Biotherapeutics to Automate its Treg Cell Manufacturing Using Cellares’ Cell Shuttle Platform MEDIPOST Doses First US Patient in Umbilical Cord Stem Cell Therapy for Knee Osteoarthritis Phase 3 Replacing Magnetic Separation with Buoyancy: A Closer Look at Bracco’s New Cell Selection Platform, BubbleGen™ Vyriad Begins Mayo Clinic CAR-T Phase 1 for Multiple Myeloma Novo Nordisk Publishes Results from Embryonic Stem Cell-Derived Dopaminergic Cells for Parkinson’s Phase 1/2 Kenai Therapeutics Completes Enrollment of Phase 1b/2a Parkinson’s iPSC Trial Aspen Neuroscience Nabs FDA RMAT Designation for its Parkinson’s Cell Therapy Life Biosciences Doses First Patient in Phase 1 of ER‑100 for Optic Neuropathies, Aiming to Rejuvenate Aging Cells CREATE Medicines to Launch First Phase 1/2 In Vivo Trial of CAR-T Candidate CRT-402 for Autoimmune Diseases in Australia Guts & Glory: Both of Cynata’s iPSC Trials Flop, GVH Phase 2 and KOA Phase 3 Cell Therapies to Manufacture CAR-T Therapy for Phase 1/2b Solid Tumor Trial in Australia FDA Selects Seven Participants for PreCheck Pilot Program to Advance US Drug Manufacturing Webinar: Inside eXmoor’s Cell & Gene GMP Facility, Designed for Uncertainty Orca Bio Nabs FDA Approval of TREGZI, its Cell Therapy for Allogeneic Transplant in Adults with Blood Disorders Aspen Neuroscience Completes Cohort 3 and 4 Dosing in iPSC-Derived Phase 1/2a for Parkinson’s CARsgen Nabs Chinese Approval of Satri-cel, its CAR-T Therapy for Stomach Cancer REPROCELL Receives Commercialization Award from Maryland Stem Cell Research Fund to Advance Universal, Hypoimmune iPSC Platforms First Patient Dosed in Neural Stem Cell Therapy for Huntington’s Trial at UCI Health China Launches Huge Umbilical Stem Cell Longevity RCT Hope Biosciences Publishes Positive Results from Stem Cells for TBI Study Steminent Filing for Japanese Approval of its Mesenchymal Stem Cell Therapy for Spinocerebellar Ataxia Inside Japan’s Regenerative Medicine Laws: JSRM Explains Heartseed Doses First Patient in Historic iPSC-Derived Cardiomyocyte Trial Via Catheter Verismo Therapeutics to Use Cryoport’s IntegriCell® Cryopreservation Services in its Clinical KIR-CAR T Cell Therapy Programs CIRM Approves $662M Regen Med Funding, Largest in its History UniXell Biotechnology Nabs IND Clearance for its iPSC Parkinsons Therapy, UX-DA003 FDA Unveils its Plan for Operation TrialBlazer, Hoping to Streamline Drug Development Timelines FDA Reverses Decision on Regenxbio’s Gene Therapy for Hunter’s Syndrome, Supporting BLA Resubmission for Accelerated Approval Cellares Joins New American Industrial Alliance, Advancing U.S. Biopharmaceutical Manufacturing Independence Hopstem Bio Nabs Phase 2 Approval for its iPSC-Derived Neural Cell Therapy for Chronic Ischemic Stroke Georgia Joins Utah, Florida, and Other States in “Legalizing” Birth Tissue-Derived Stem Cell Therapies TriCelX Nabs FDA Clearance for Phase 1/2 of First-in-Indication Cell Therapy Trial for CTE iPSC Race Heating Up: Cynata To Report Phase 3 iPSC-Derived Mesenchymal Stem Cell for Knee Osteoarthritis Soon ElpasBio Completes Patient Enrollment in Phase III Trial of AlloJoin for Knee Osteoarthritis Made Scientific Selected to Manufacture Columbia University’s NOVAKnee, a 3D Printed Knee Replacement Made of Stem Cells and Scaffolds The Jackson Laboratory Nabs $1.8M Grant from The Michael J. Fox Foundation to Advance Induced Pluripotent Stem Cells for Parkinson’s Syntax Bio and Mayo Clinic Partnering on Cell Therapy for Type 1 Diabetes Cynata gains EU endorsement for Graft-vs-Host iPSC Study Plans